Breast Cancer Research and Treatment Oncology

Randomized phase II comparison of single-agent carboplatin versus combination of carboplatin and everolimus for advanced triple negative breast cancer

Rima Patel, Jami Fukui, Paula Klein, Erin Moshier, Hulya Kocyigit, Laura Fiedler, Weronika Bucwinska, Xiao Y. Xing, Charles Shapiro, Anupama Goel, Julie Fasano, Theresa Shao, Aarti Bhardwaj, Esther Kim, Rita Vaccaro, Karen Lee, Eric Wilck, Amy Tiersten
Springer Nature · 2025-08-16 · DOI 10.1007/s10549-025-07802-7

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →